Get the Stockscreener App
0.8426
5.31%
0.0425
Sunshine Biopharma Inc stock is traded at $0.8426, with a volume of 131.40K.
It is up +5.31% in the last 24 hours and down -26.09% over the past month.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
See More
Previous Close:
$0.8001
Open:
$0.838
24h Volume:
131.40K
Relative Volume:
0.26
Market Cap:
$3.27M
Revenue:
$35.49M
Net Income/Loss:
$-6.04M
P/E Ratio:
-0.0647
EPS:
-13.0191
Net Cash Flow:
$-6.42M
1W Performance:
-6.36%
1M Performance:
-26.09%
6M Performance:
-91.82%
1Y Performance:
-94.46%
1-Day Range:
$0.8014
$0.8598
1-Week Range:
$0.7779
$0.97
52-Week Range:
$0.7779
$24.30
Sunshine Biopharma Inc Stock (SBFM) Company Profile
Name
Sunshine Biopharma Inc
Sector
Phone
954-330-0684
Address
333 LAS OLAS WAY, FORT LAUDERDALE
Compare SBFM vs TAK, TEVA, HLN, ZTS, VTRS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SBFM
Sunshine Biopharma Inc
|
0.8426 | 3.27M | 35.49M | -6.04M | -6.42M | -13.02 |
TAK
Takeda Pharmaceutical Co Adr
|
18.86 | 60.23B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
39.19 | 45.71B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.26 | 40.72B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
71.05 | 29.36B | 9.51B | 2.64B | 2.14B | 6.0361 |
VTRS
Viatris Inc
|
17.83 | 20.48B | 14.57B | -296.50M | 1.64B | -0.259 |
Sunshine Biopharma Inc Stock (SBFM) Latest News
Sunshine Biopharma, Inc. (SBFM) Stock Price, News, Quote & History - Yahoo Finance
Sunshine Biopharma, Inc. (SBFM) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
SBFM Looks 59.3% Undervalued on GF Value™ Despite Distressed Fun - GuruFocus
Sunshine Biopharma launches generic ondansetron in Canada - Investing.com
Sunshine Biopharma launches generic ondansetron in Canada By Investing.com - Investing.com India
Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care Portfolio - Weatherford Democrat
A generic drug for nausea during cancer treatment launches in Canada - stocktitan.net
Sunshine Biopharma Stock (SUNB) Opinions on Coronavirus Drug Studies - Quiver Quantitative
Sunshine Biopharma Inc (SBFM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Sunshine Biopharma Authorizes Reverse Stock Split of Up to 1-for-20 - Minichart
Sunshine Biopharma CEO Authorizes Potential Reverse Stock Split - TipRanks
SBFM Looks 51.6% Undervalued on GF Value™ Despite Distressed Fun - GuruFocus
Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies - Weatherford Democrat
An oral drug candidate suppressed lung virus in infected mice - Stock Titan
EXCLUSIVE: Sunshine Biopharma Advances 'Differentiated Antiviral Candidate' to IND-Enabling Studies - Yahoo Finance
Sunshine Biopharma Adjusts Series B Warrant Exercise Price - TipRanks
Form 8K Sunshine Biopharma Inc For: 11 September By Investing.com - Investing.com South Africa
Sunshine Biopharma reduces Series B warrant exercise price to $1.2046 By Investing.com - Investing.com South Africa
Sunshine Biopharma reduces Series B warrant exercise price to $1.2046 - Investing.com
Sunshine Biopharma (NASDAQ: SBFM) Anticipates $31M from Series B Warrant Exercises - kalkinemedia.com
Price to earnings forward of Sunshine Biopharma Inc. – BOATS:SBFMW - TradingView
Price to sales forward of Sunshine Biopharma Inc. – BOATS:SBFMW - TradingView
Sunshine Biopharma Inc. SEC Filing (Sep 9, 2026) - Stock Titan
Sunshine Biopharma receives Canadian approval for atenolol tablets By Investing.com - Investing.com Nigeria
Sunshine Biopharma Announces Board Vacancy as Dr. Andrew Keller Steps Down After Term Ends - kalkinemedia.com
SBFM Looks 52.9% Undervalued on GF Value™ Despite Weak Fundamentals - GuruFocus
Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions - Cadillac News
Health Canada approves Atenolol, a drug used for high blood pressure and chest pain - Stock Titan
Sunshine Biopharma Inc. Warrant (SBFMW) Key Financial Ratios – Valuation, Profitability & More - Value Research
Sunshine Biopharma Inc. Warrant (SBFMW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Sunshine Biopharma (NASDAQ: SBFM) could raise $31M from warrants - Stock Titan
Dr. Andrew Keller to Leave Sunshine Biopharma Board at Term End - TradingView
Sunshine Biopharma Inc. Announces Term Completion of Dr. Andrew Keller as Director - marketscreener.com
Sunshine Biopharma Inc. (SBFM) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Sunshine Biopharma Inc. (SBFM) Peer Comparison – Compare with Others - Value Research
Sunshine Biopharma Reports In Vivo Tumor Suppression with K1.1 mRNA and Advances Novel mRNA-Cancer Vaccine Strategy for Lung Cancer - The Batesville Daily Guard
Sunshine (SBFMW) Market: Closes Nearly Flat at $0.05 in the Available Record; Levels: the Current Price Sits Inside the Supplied Technical RangeExhaustion Gap - vinanet.vn
Sunshine Biopharma wins Canadian approval for generic Enalapril tablets - Bitget
SBFM Looks 55.2% Undervalued on GF Value™ Despite Challenging Fu - GuruFocus
BRIEF-Sunshine Biopharma Receives Canadian Regulatory Approval For Enalapril - Bitget
Sunshine Biopharma receives Canadian approval for generic enalapril By Investing.com - Investing.com Canada
Sunshine Biopharma receives Canadian approval for generic enalapril - Investing.com
Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market - Eagle-Tribune
EXCLUSIVE: Sunshine Biopharma Secures Canadian Approval for Generic Hypertension Drug - Yahoo Finance
Sunshine (SBFM) Quarterly Performance Check: The Company Lists Its Latest Available Figures in the Reported Period; Session Reaction: The Stock Ends Up 1.79% in the Latest ReadingEarnings Momentum Score - vinanet.vn
101,973 Common Stock of Sunshine Biopharma, Inc. are subject to a Lock-Up Agreement Ending on 18-AUG-2026. - marketscreener.com
Sunshine Biopharma earnings beat by $0.05, revenue topped estimates - Investing.com
SBFM Q1 2026 Earnings: Clinical-Stage Biotech Posts $0.25 Per-Share Loss as Shares Slip 4.17%Revenue Warning Signal - vinanet.vn
SBFM Q1 2026 Earnings: Reported Loss of $0.25 Per Share as Stock Declines 4.17%Pre-Earnings Setup - Vinanet
Sunshine Biopharma Inc (NASDAQ: SBFM) Share Price, SBFM Stock News, SBFM Share Price & Updates - kalkine.ca
SBFM Q1 2026 Earnings: Net Loss of -$0.25 Per Share as Pre-Revenue Oncology Developer Presses OnForward Guidance Trends - vinanet.vn
Sunshine Biopharma Inc Stock (SBFM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.18%
0.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):